Latest breast cancer news from medicineworld.orgMedicineWorld.Org brings daily breast cancer news from various sources to keep you updated on the latest events in the world of breast cancer. Medicineworld cancer news service is the most comprehensive cancer news service on the internet. We keep an archive of previous few days of news on this site. Please go down through the list to find the older news items.Women well informed about breast cancer- June 13, 2007 As per a new GfK Roper Public Affairs survey sponsored by CancerCare, a national nonprofit cancer support organization, while the majority (76 percent) of women surveyed said they know at least a fair amount about breast cancer, a number of remain unaware of the important recent progress made in therapy. Fewer than one out of four (23 percent) women ages 50-65 have heard of new therapies for breast cancer, revealing a gap between awareness and information that women can use toward better...http://medicineworld.org/cancer/lead/6-2007/women-well-informed-about-breast-cancer.html Raloxifene as Effective as Tamoxifen in Preventing Breast Cancer- June 13, 2007 The largest North American breast cancer prevention trial, the Study of Tamoxifen and Raloxifene, or STAR trial, has compiled an initial analysis of study data and found the osteoporosis drug raloxifene works as well as tamoxifen in reducing breast cancer risk for postmenopausal women at increased risk of the disease. Both drugs reduced the risk of developing invasive breast cancer by about 50 percent........http://medicineworld.org/cancer/lead/4-2006/raloxifene-as-effective-as-tamoxifen.html Older Breast Cancer Patients May Be Under-treated- June 13, 2007 Elderly breast cancer patients who received care in a community hospital setting may have been under-diagnosed, under-staged and under-treated, as per a report in the recent issue of Archives of Surgery, one of the JAMAArchives journals. The number of older patients with breast cancer has increased along with overall elderly population, as per background information in the article. About half of patients with breast cancer are older than 65 years and 35 percent are older than 70; 77 percent of..http://medicineworld.org/cancer/lead/10-2006/older-breast-cancer-patients-may-be-under-tre... Women With Mental Disorders And Mammograms- June 13, 2007 Women with mental disorders are less likely to have screening mammograms than women without mental illness, although. the nature of the mental illness does play a role, as per a large study published by Indiana University School of Medicine and Richard Roudebush VA Health Services Center for Excellence scientists in the recent issue of Journal of General Internal Medicine. Previous to this study, little was known about whether the type or severity of mental illness influences receipt of...http://medicineworld.org/cancer/lead/10-2006/women-with-mental-disorders-and-mammograms.ht... Targeting Protein S14 In Breast Cancer Treatment- June 13, 2007 William Kinlaw, an associate professor of medicine at Dartmouth Medical School, has been working on a protein called S14 since 1990. Over the past few months, however, the news about S14 has picked up. Through a series of recently published academic studies, Kinlaw and colleagues are ready to pronounce S14 a potential drug target in treating breast cancer........http://medicineworld.org/cancer/lead/8-2006/targeting-protein-s14.html How Multiple Copies Of A Gene Affect Metastasis- June 13, 2007 Scientists at UT Southwestern Medical Center have for the first time described how multiple copies of a gene are responsible for metastases in early-stage breast cancer and poor prognosis for patients. As per a research findings published in this week's issue of the Proceedings of the National Academy of Sciences, the gene, called uPAR, offers a promising target for therapeutic drugs to stop or slow the progression of the disease and could serve as a screening tool for assessing which types of..http://medicineworld.org/cancer/lead/10-2006/how-multiple-copies-of-a-gene-affect-metastas... Estrogen Alone HRT Does Not Increase Breast Cancer Risk- June 13, 2007 New research is suggesting that estrogen may not be as bad it was thought in terms of breast cancer risk. Scientists have found that estrogen-alone hormone treatment does not increase the risk of breast cancer in postmenopausal women. This result comes from an updated analysis of the Women's Health Initiative (WHI) Estrogen-Alone Trial........http://medicineworld.org/cancer/lead/4-2006/estrogen-alone-hrt-does-not-increase-breast-ca... Psychological Needs Of Breast Cancer Patients- June 13, 2007 Almost half of newly diagnosed patients with breast cancer are found to have clinically significant emotional distress or symptoms of psychiatric disorders before therapy is begun, as per a new study reported in the recent issue of CANCER, a peer-evaluated journal of the American Cancer Society. The study reveals that while virtually all of the women admitted to,experiencing some level of emotional distress, 47 percent met clinically significant screening criteria for emotional distress or a...http://medicineworld.org/cancer/lead/11-2006/psychological-needs-of-breast-cancer-patients... "DES Daughters" And Risk Of Breast Cancer- June 13, 2007 So-called "DES daughters," born to mothers who used the anti-miscarriage drug diethylstilbestrol during pregnancy, are at a substantially greater risk of developing breast cancer compared to women who were not exposed to the drug in utero. Reporting in the recent issue of the journal Cancer Epidemiology, Biomarkers and Prevention, a nationwide team of researchers found that DES daughters over age 40 had 1.9 times the risk of developing breast cancer, compared to unexposed women of the same age..http://medicineworld.org/cancer/lead/8-2006/des-daughters-and-risk-of-breast-cancer.html International Trial Of Novel Breast Cancer Drug- June 13, 2007 A clinical trial of a new targeted breast cancer drug, led by physicians at Massachusetts General Hospital (MGH) Cancer Center, has begun enrolling patients. The TEACH (Tykerb Evaluation After CHemotherapy) trial will investigate the experimental drug Tykerb (lapatinib) in patients with early-stage, HER2-positive breast cancer who have not been treated with Herceptin, another targeted drug used for the same type of tumor. The MGH is the lead institution for the international trial, which is...http://medicineworld.org/cancer/lead/12-2006/international-trial-of-novel-breast-cancer-dr... |